Voices In Validation

Voices In Validation

Download on the App Store

Voices In Validation episodes

  • 8 Essentials of Designing for Manufacturability

    Stacey Bruzzese welcomes Roberta Goode back to the show. Today, Stacey and Roberta will be covering the essentials of designing for manufacturability.

     

    • Roberta details the 8 essentials of DFM
  • Why is Designing for Manufacturability important for medical device manufacturers?
  • Does standardization of materials help shorten the product development cycle?
  • What’s the next step after determining the practical part count?
  • What is Poka-Yoke?
  • What other points should be considered when scaling up manufacturing?
  •  

    DFMA References

    Assembly Automation and Product Design

    G. Boothroyd, Marcell Dekker, Inc. 1992

    Product Design for Manufacture and Assembly

    G. Boothroyd and P. Dewhurst, G. Boothroyd Dewhurst, Inc. 1989

    Marcell Dekker, Inc.  1994

    Design and Analysis of Manufacturing Systems

    Prof. Rajan Suri University of Wisconsin  1995

    Product Design for Assembly: The Methodology Applied

    G. Lewis and H. Connelly

    Simultaneous Engineering Study of Phase II Injector Assembly Line

    Giddings & Lewis  1997

    Design for Manufacturing Society of Manufacturing Engineers,

    (VIDEO)

    Introduction to Design for (Cost Effective) Assembly and Manufacturing David

    Steinstra, Rose-Hulman, 2015

    IVT’s Medical Device Handbook: http://www.ivtnetwork.com/article/medical-device-validation-handbook

    Twice awarded IVT’s Speaker of the Year, Roberta Goode is the founder of Goode Compliance, where she created over 350 jobs, forming an astonishingly talented team of biomedical engineers.  After she and her team remediated enforcement actions for 17 of the world’s 20 largest medical device manufacturers, Roberta turned her attention to sharing that wealth of accumulated knowledge.  In 2018, she founded Altrec, LLC to lead paradigm-shifting programs including CDRH’s Benefit-Risk Collaborative Community, and to provide custom technical training and mentoring to the medical device industry.   

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    43 min
  • What’s Trending and Timely in Life Sciences?

    On this episode, Stacey Bruzzese is joined by Karen Ginsbury, President & CEO of PCI Pharmaceutical Consulting Israel. Stacey and Karen talk about what’s new with global systems and regulatory guidelines.

     What’s new in Quality Management System

    • For Virtual companies, what are their responsibilities in terms of quality systems?
  • What’s the new EU guidance around vendors and responsibility?
  • What will the impact be of new Draft PIC/S recommendations on how to demonstrate the effectiveness of a Pharmaceutical Quality System?
  • What are the differences in protocols for QRM systems in digitally enabled and fully automated labs?
  • What’s happening with Annex 1?
  • More information on the topics discussed can be found at:

    ISO 18091:2019

    Quality management systems — Guidelines for the application of ISO 9001 in local government

         https://www.iso.org/standard/72808.html

    Validation Week 2020

           http://www.cbinet.com/conference/pi20083

    FDA Information on PQS

          https://www.fda.gov/media/92818/download

    ICH Q10 Quality Management

          https://www.fda.gov/media/71553/download

    IT and Computerized Systems Conference

         http://www.cbinet.com/conference/pi20045

    ICH guideline Q10 on pharmaceutical quality system

     http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002871.pdf

    ICH guideline Q9 on quality risk management

         http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002873.pdf

    Karen has over twenty years of experience in the pharmaceutical industry. ... After leaving Teva, Karen set up her own consultancy company, PCI Pharmaceutical Consulting Israel Ltd which has been providing services to the pharmaceutical industry worldwide for the past 14 years.Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    40 min
  • Change Management: Beyond the SOP

    On this episode, Stacey Bruzzese welcomes back Dr. Siegfried Schmitt, Vice President Regulatory and Access at PAREXEL.  They discuss change management and the variety of factors that contribute to successful implementation.

     

    • What is included in a solid change management SOP?
  • What are the best practices for identifying level of risk to products or systems?
  • What is the best way to handle changes that are urgent, planned or temporary?
  • What best practices exist for pre-approvals to changes in a like-for-like change scenario?
  • Siegfried provides insights into streamlining the requirements of the change control process
  • Siegfried shares some examples of GMP deficiencies and the specific findings
  • What are the most important takeaways from the discussion?
  • Dr. Siegfried Schmitt is Vice President, Regulatory and Access, at PAREXEL Consulting, where he has worked at developing and improving quality management systems; including Quality by Design and Control Strategies since 2007. He is a Thought Leader in Competitive Compliance, Data Integrity and Supply Chain, as well as a trusted expert for regulatory, compliance and industry-best-practices projects. Siegfried has more than 30 years’ experience in the healthcare industry, spanning manufacture, analytics, validation and quality assurance. He received his Ph.D. in Organic Chemistry from the University of Berne, Switzerland and is a Fellow of the Royal Society of Chemistry.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    28 min
  • Change Control for Existing Products

    Stacey Bruzzese welcomes Alan Golden from Design Quality Consultants. Stacey and Alan have a conversation about a wide variety of change control topics.

    • Alan gives a brief review of the product lifecycle
  • When does change control start and end for a product?
  • What should be included in change control SOP?
  • Is the process of change control vastly different during development and post market?
  • What are the key drivers for post-launch changes?
  • What is unique about the review and documentation processes for post launch?
  • What differs between pro-active versus reactive changes?
  • What tools can be used for identifying the true effect of a change?
  • What are the most common pitfalls to change control compliance?
  • Alan has over 30 years of experience in the medical device industry, both in basic research and in quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents and published numerous papers and abstracts. Alan then transitioned to a quality assurance role where in both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support and operations.

    Alan’s quality assurance experience extends from design control, change control, risk management, CAPA, process and test method validation and statistics. He has been lecturing on these topics worldwide for over 10 years.

    Alan retired from Abbott in 2018 and now runs Design Quality Consultants, providing training, workshops and seminars in many areas of quality assurance.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    42 min
  • Data Integrity: Hidden issues and Blind Spots

    On today’s episode, Stacey Bruzzese welcomes Dr. Siegfried Schmitt, Vice President Regulatory and Access at PAREXEL.  They discuss how to avoid blind spots when it comes to data integrity.

    • What systems and processes need to be included in my Data Integrity program?
  • Who is responsible for oversight?
  • Siegfried talks about a common misconception about electronic data
  • Are informal notes and brainstorming sessions part of the data integrity equation?
  • Why are so many of us not adhering to our own internal policies?
  • How can I increase awareness to potential data integrity issues?
  • Stacey and Siegfried discuss violations in conduct
  • What is managements role in these cases?
  • Siegfried shares some strategies for identifying hidden issues
  • Dr. Siegfried Schmitt is Vice President, Regulatory and Access, at PAREXEL Consulting, where he has worked at developing and improving quality management systems; including Quality by Design and Control Strategies since 2007. He is a Thought Leader in Competitive Compliance, Data Integrity and Supply Chain, as well as a trusted expert for regulatory, compliance and industry-best-practices projects. Siegfried has more than 30 years’ experience in the healthcare industry, spanning manufacture, analytics, validation and quality assurance. He received his Ph.D. in Organic Chemistry from the University of Berne, Switzerland and is a Fellow of the Royal Society of Chemistry.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com

    31 min
  • Audit Trails and Data Integrity in Pharmaceutical and Life Sciences

    On today’s episode, Stacey Bruzzese welcomes Ivan Soto, Director Manufacturing Validation for Emergent BioSolutions. They discuss a variety of aspects around the topic of data integrity.

     

    • Why are we hearing more about audits and audit reviews lately?
  • Ivan talks about the history of audit trail reviews and the current challenges
  • Why are audit trails important to safety, efficacy and reliability or pharmaceuticals and how does that impact data integrity efforts?
  • Why is it important to assess the products’ entire legacy or history?
  • Ivan shares advice on the frequency of periodic reviews and what should be included in those reviews
  • He shares some tips for simplifying the review process
  • Where does Ivan see the industry moving regarding audit trails?
  • Ivan has been in the life science industry for over 20 years and held several technical and management positions at different Pharmaceutical companies in the areas of Validation, IT Compliance, Quality Control and Quality Assurance. In his previous role under his leadership, his team successfully implemented a lean validation program. He is an active speaker at conferences related to validation cost reduction and efficiency improvements. He is also a contributing editor for the Journal of GxP Compliance and Validation Technology. He has a (B.S) in Chemistry from the Catholic University of Puerto Rico.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com

    30 min
  • What Can I Expect During an Audit?

    On today’s episode, Stacey Bruzzese presents a recording with clips from a mock audit. The mock audit was recorded at a recent IVT conference and was facilitated by Alyce Deegan, Vice President of Data Integrity at Compliance Path LLC.

    • What factors impede a zero-findings review?
  • How can I prepare for an audit review?
  • What can I expect from the inspectors?
  • What kinds of questions do they ask?
  • What is the best way to answer these questions?
  • These questions and more are covered during the mock audit. This episode has a lot of useful tips for anyone preparing for an audit. For additional information about Alyce’s presentation got to http://www.ivtnetwork.com/article/data-integrity-mock-inspection-mitigating-risk

     

    Alyce Deegan has over 20 years of experience in Pharmaceutical, Medical Device and Gene Therapy industries.  Most recently, Alyce was the IT Director of Manufacturing and GxP Lab Systems at Juno Therapeutics a CAR-T Cell Therapy Manufacturing Plant located in Bothell, WA.  Throughout Alyce’s career she has held leadership positions in Quality, Validation and IT at companies such as Pfizer, Biogen and ThermoFisher.  Throughout her career she has built and continues to build "Unified Compliance Models" within companies to address the ever changing regulations and has been directly involved with multiple agency inspections throughout the years.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    40 min
  • Testing Automation – The Impact of Increasing Technology on CSV Processes

    On today’s episode, Stacey Bruzzese welcomes Valarie King-Bailey back to talk about testing automation and how new technologies impact Computer Systems Validation (CSV).

    Stacey and Valarie cover a variety of topics:

    • With Parma moving toward AI, IoT, Big Data and more, what are some of the trends specific to Computer Systems Validation?
  • Over the next 12 months, what are some of the greatest obstacles to full integration of technologies for pharma companies?
  • How do manufacturers choose between on-site servers, private cloud and public cloud options?
  • What does the hosting choice mean for Cybersecurity professionals supporting the life science space?
  • What will the impact be on traditional Computer Validation best practices?
  • What does an integrated solution look like, and what steps must industry leaders take to move in the right direction?
  • What parting thought does Valarie have for the listener?
  •  

    Valarie King-Bailey, is CEO of OnShore Technology Group –a Chicago-based global IV&V firm. Valarie has over 30 years of validation experience in the engineering and life sciences disciplines. She has conducted validation exercises for leading life sciences companies across the globe. She holds a B.S. in Civil & Environmental Engineering from the University of Wisconsin -Madison and an MBA in Information Systems from Keller Graduate School of Management. She received a lifetime achievement award from the University of Wisconsin College of Engineering and is a UW College of Engineering Distinguished Alumni.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    25 min
  • The intricacies of Computer System Validation in the Pharmaceutical industry

    On today’s episode, Stacey Bruzzese welcomes Chris Wubbolt to talk about validation of manufacturing equipment, processes and computer systems – both hardware and software.

    Stacey and Chris talk about a variety of topics:

    • Chris gives a brief overview of CSV and why it’s important to the integrity of the product
  • Chris explains why, in an FDA regulated laboratory, CSV is not only concerned with computer hardware and software
  • What is the impact on the Pharma industry of going paperless and relying more on computer documentation?
  • What are some of the biggest hurdles for compliance?
  • What are some of the best practices for big data and data integrity?
  • How will implementing more technologies like IoT and AI impact CSV?
  • Where does Chris see things heading in the future?
  • Chris has over 25 years’ experience in regulated industry and has provided compliance, quality assurance and computer validation consulting services. He remains current in industry trends and requirements and frequently speaks or provides workshops at leading industry conferences and programs. Chris has a master’s Degree in Quality Assurance and Regulatory Affairs and a BS in Physics and Computer Engineering, along with a Six Sigma Black Belt Certification.

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    32 min
  • Part 3 of Get Your Medical Device to Market in 10 Easy Steps: Product Launch

    On today’s episode, Stacey Bruzzese welcomes Roberta Good, the founder of Goode Compliance for the final part of our 3-part series.  Stacey and Roberta review the steps necessary for a successful product launch.

    Stacey and Roberta cover a variety of topics:

    • Roberta outlines the steps associated with the final phase prior to product launch
  • Do you still need to be thinking about verification and validation?
  • Is this the right time to be thinking about marketing and branding?
  • What data are you looking for with a product release into Limited Test Markets or Clinical Trial Sites?
  • How thorough should your completed technical documentation need to be prior to full product launch?
  • Roberta reviews all that is needed to fully launch the product
  • What does the post-market surveillance entail and how long does it take to complete?
  • What are the best practices for capturing this data?
  • How does cloud-based computing affect the requirement for maintaining post-market data integrity?
  • What kinds of problems could occur after product launch?
  • Roberta talks about how listeners can make use of the information presented in this 3-part series
  • The following links have useful companion information for this episode:

    Post-Market Requirements:

    https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/postmarket-requirements-devices

    IVT’s Medical Device Validation Handbook:

    http://www.ivtnetwork.com/article/medical-device-validation-handbook

    Twice awarded IVT’s Speaker of the Year, Roberta Goode is the founder of Goode Compliance, where she created over 350 jobs, forming an astonishingly talented team of biomedical engineers.  After she and her team remediated enforcement actions for 17 of the world’s 20 largest medical device manufacturers, Roberta turned her attention to sharing that wealth of accumulated knowledge.  In 2018, she founded Altrec, LLC to lead paradigm-shifting programs including CDRH’s Benefit-Risk Collaborative Community, and to provide custom technical training and mentoring to the medical device industry.   

    Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.

    45 min

About Voices In Validation

From the publisher's feed

Our host, Stacey Bruzzese interviews industry experts from pharma, biotech, med devices and laboratories.